v3.22.2.2
Acquisition, Discontinued Operations, Equity-Method Investment and Collaborative Arrangement - Equity Method Investment Narrative (Details)
€ in Millions, £ in Millions, $ in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2022
USD ($)
Jul. 31, 2022
GBP (£)
Oct. 02, 2022
USD ($)
Oct. 03, 2021
USD ($)
Oct. 02, 2022
USD ($)
Oct. 03, 2021
USD ($)
Jul. 18, 2022
Jul. 03, 2022
USD ($)
Jul. 03, 2022
GBP (£)
Mar. 31, 2022
USD ($)
Mar. 31, 2022
EUR (€)
Mar. 31, 2022
GBP (£)
Dec. 31, 2021
USD ($)
Jul. 31, 2019
Schedule of Equity Method Investments [Line Items]                            
Equity-method investments     $ 9,826   $ 9,826               $ 16,472  
Dividends received, return of capital         3,960 $ 0                
Other short-term borrowings, principal amount [1]     1,474   1,474               605  
1.365% Consumer Healthcare JV Loan [Member] | Loans Payable [Member]                            
Schedule of Equity Method Investments [Line Items]                            
Debt instrument, face amount | £                 £ 2,900          
Other short-term borrowings, principal amount               $ 3,700            
Stated interest rate               1.365% 1.365%          
Repurchase amount | £   £ 2,900                        
Consumer Healthcare JV / Haleon [Member]                            
Schedule of Equity Method Investments [Line Items]                            
Equity method investment, ownership percentage             32.00%     32.00% 32.00% 32.00%   32.00%
Equity-method investments     9,600   9,600               $ 16,300  
Equity-method investment, quoted market value     9,100   9,100                  
Dividends received, total $ 4,200 £ 3,500     4,500                  
Dividends received, return of capital $ 4,000       4,000                  
Dividend received, distribution         584                  
Decrease due to foreign currency translation         2,400                  
Equity method investment earnings     67 $ 106 402 $ 324                
Equity method investment, adjustment of basis differences     $ 118   $ 119                  
GSK [Member] | Consumer Healthcare JV / Haleon [Member] | Disposed of by Sale [Member]                            
Schedule of Equity Method Investments [Line Items]                            
Proposed percent of ownership disposal                   80.00% 80.00% 80.00%    
GSK [Member] | Consumer Healthcare JV / Haleon [Member]                            
Schedule of Equity Method Investments [Line Items]                            
Equity method investment, ownership percentage                           68.00%
Consumer Healthcare JV / Haleon [Member] | Senior Notes [Member] | Senior Notes, USD Denominated [Member]                            
Schedule of Equity Method Investments [Line Items]                            
Debt instrument, face amount                   $ 8,750        
Consumer Healthcare JV / Haleon [Member] | Senior Notes [Member] | Senior Notes, EUR Denominated [Member]                            
Schedule of Equity Method Investments [Line Items]                            
Debt instrument, face amount | €                     € 2,350      
Consumer Healthcare JV / Haleon [Member] | Senior Notes [Member] | Senior Notes, GBP Denominated [Member]                            
Schedule of Equity Method Investments [Line Items]                            
Debt instrument, face amount | £                       £ 700    
[1] Primarily includes cash collateral. See Note 7F.